Page 12 of 15
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
This article is part of a Supplement: Volume 2013 Supplement 1
17β-Hydroxysteroid dehydrogenase type-3 (17βHSD-3) deficiency is a rare cause of 46,XY disorders of sex development. The enzyme converts androstenedione to testosterone, necessary for masculinization of male g...
Prader-Willi syndrome (PWS) is a complex genetic disorder, caused by lack of expression of genes on the paternally inherited chromosome 15q11.2-q13. In infancy it is characterized by hypotonia with poor suck r...
The original article was published in International Journal of Pediatric Endocrinology 2010 2010:159402
Four topics from the DSD Working Party, a meeting to provide information regarding future studies, reported here are the complexities of hypospadias, surgical treatment of virilized genitalia of 46,XX DSD indi...
Leri-Weill syndrome (LWS) is a genetic disorder caused by deletions or mutations in the SHOX gene or by deletions downstream of the gene and is classically characterized by short stature, mesomelic shortening ...
It is possible that genes on the X chromosome are expressed differently depending of its parental origin. The objective of this study was to determine the influence of the parental origin of the X-chromosome o...
Models assessing characteristics contributing to response to recombinant human growth hormone (rhGH) response rarely address growth extremes in both years 1 and 2 or examine how children track from year to yea...
Continuous glucose monitoring (CGM), while a relatively new technology, has the potential to transform care for children with type 1 diabetes. Some, but not all studies, have shown that CGM can significantly i...
To catalogue patients with DSD and to assess the concordance of genotype and phenotype with sex assignment at birth compared to sex assignment before and following assessment by a Gender Medicine Team (GMT) at...
Many patients with childhood-onset growth hormone (GH) deficiency do not fulfill diagnostic criteria for GH deficiency (GHD) after attainment of adult height and may not require long-term GH treatment. Patient...
The relationship between congenital hypothyroidism (CH) and multiple pregnancy has not been fully studied in Japan.
To identify factors that predict low bone mineral density (BMD) in pediatric patients referred for dual-energy x-ray absorptiometry assessments.
Hyperinsulinism (HI) is the leading cause of persistent hypoglycemia in children,which if unrecognized may lead to development delays and permanent neurologicdamage. Prompt recognition and appropriate treatmen...
Growth rate In children is reported to have seasonal variability. There are fewer published data regarding seasonal variability while on growth hormone (GH) therapy, and none analyzing growth rate with respect...
To compare outcomes between children (<18 yrs) and adults undergoing total thyroidectomy for Graves’ disease (GD) at a high volume, multidisciplinary thyroid center.
Laboratory measurements of hemoglobin A1c above 6.5% were approved as an additional diagnostic criteria for diabetes mellitus by the American Diabetes Association in 2010. Several recent pediatric studies have...
Children treated with stimulant medication for attention deficit hyperactivity disorder (ADHD) often lose weight. It is important to understand the implications of this during growth. This prospective study wa...
Prospective memory is that memory which is required to carry out intended actions and is therefore essential in carrying out the daily activities required in the self-management of type 1 diabetes mellitus (T1...
This review summarizes the technologies in use and in the pipeline for the management of diabetes. The review focuses on glucose meters, continuous glucose monitoring devices, insulin pumps, and getting clinic...
Recent studies have described relationships between iron status and fibroblast growth factor-23 (FGF23) but the possible confounding effects of inflammation on iron status have not been considered. The aims of...
McCune-Albright Syndrome (MAS) is usually characterized by the triad of precocious puberty (PP), fibrous dysplasia, and café au lait spots. Previous treatments investigated for PP have included aromatase inhib...
Patients with Multiple Endocrine Neoplasia type 2 (MEN 2) are at high risk of developing aggressive medullary thyroid carcinoma (MTC) in childhood, with the highest risk in those with MEN type 2B (of whom >95%...
Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12–21 years. Based on our experience, future studies will require multiple centers to ...